Eyenovia Announces FDA Acceptance of IND Application for MicroPine to Reduce the Progression of Myopia

Eyenovia (NASDAQ:EYEN) has announced that the US Food and Drug Administration has accepted its Investigational New Drug (IND) application to...

What is In-licensing?

In-licensing may be pharma’s preferred mode of business development these days. Should that impact your investment strategy?

Big News Roundup: Pacton Acquires “Golden Palms” Ground in Egina Area, Pilbara; Nevada Copper Hits with 19 Mineralized Holes: Enhances Potential of Open Pit Economics; First Cobalt Announces Inferred Mineral Resource for Iron Creek Project – Open at Depth and Along Strike

In case you missed it, here is this week's big news roundup.

Advantage Lithium Commences Preliminary Economic Assessment and Phase III Resource Conversion Program for the Cauchari Definitive Feasibility Study

Advantage Lithium Corp (TSXV:AAL; OTCQX:AVLIF) is pleased to announce that is has engaged WorleyParsons Chile S.A. (WP) to complete a...

U.S. FDA Clears Pluristem’s Phase III Study in Treatment of Muscle Injury Following Hip Fracture Surgery

Pluristem Therapeutics (Nasdaq:PSTI) a leading developer of placenta-based cell therapy products, announced today that the U.S. Food and Drug Administration (FDA)...

SilverCrest Delineates 10th High-Grade Vein at Las Chispas

SilverCrest Metals Inc. announced drill results from the Luigi vein on the Las Chispas property located in Sonora, Mexico.

Data Monitoring Committee Completes Planned Safety and Data Review of Celsion’s Phase III OPTIMA Study

Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, today announced that the independent Data Monitoring Committee (DMC) for the Company’s...